By ’
CSIMarket.com Staff Writer
In a significant move poised to transform epidural procedures, Milestone Scientific Inc. (NYSE: MLSS) announced a strategic alliance with Axial Biologics to distribute its pioneering CompuFlo Epidural System in New Jersey, Texas, and Florida. This collaboration, revealed on August 7, 2024, underlines the ongoing efforts to enhance medical technology and patient care.
Milestone Scientific, a prominent developer recognized for its computerized drug delivery instruments, aims to ensure painless and precise injections with its CompuFlo Epidural System. The system uses advanced technology to provide real-time data, significantly improving the accuracy and safety of epidural placements. By leveraging these innovations, Milestone Scientific continues to lead advances in pain management and medical precision.
Axial Biologics, a distinguished medical device company with an extensive distribution network, will play a crucial role in this partnership by serving as the distributor for the CompuFlo System across the specified states. The alliance is designed to expand the reach of this groundbreaking system, making it accessible to a broader range of medical professionals and patients.
The CompuFlo Epidural System represents a significant leap forward from traditional methods, offering a much-needed solution to the challenges faced in epidural procedures. Traditional epidural placements can be fraught with difficulties, including inaccurate placements that can lead to complications and patient discomfort. The CompuFlo System mitigates these issues by providing precise location data, effectively minimizing the risks associated with epidural administration.
We are thrilled to partner with Axial Biologics, a company that shares our commitment to advancing medical technology and improving patient outcomes, remarked Arjan Haverhals, CEO of Milestone Scientific. Our collaboration will enable us to bring the benefits of the CompuFlo Epidural System to more patients and healthcare providers in New Jersey, Texas, and Florida.
Similarly, David Gray, CEO of Axial Biologics, expressed optimism about the partnership. Integrating Milestone Scientific’s innovative CompuFlo System into our distribution network aligns perfectly with our mission to deliver cutting-edge medical technologies to healthcare providers. We are excited about the opportunities this partnership presents.
As healthcare continues to evolve, collaborations like the one between Milestone Scientific and Axial Biologics are essential for driving progress. By combining their expertise and resources, these companies are well-positioned to address critical challenges in pain management and enhance the quality of care for patients undergoing epidural procedures.
The partnership marks a significant step forward in the medical field, with the potential to set new standards for epidural injections. By ensuring accurate and painless procedures, the CompuFlo Epidural System can significantly improve patient experiences and outcomes.
Comments